- Going concern
- No material uncertainty
- Principal risks
- 4
| 15 Sept 2026 | 07:00:03 | Half-Year Report |
| 14 May 2026 | 15:51:34 | Change of Registered Office |
| 11 May 2026 | 13:27:52 | Holding(s) in Company |
| 11 May 2026 | 13:11:51 | Holding(s) in Company |
| 11 May 2026 | 13:08:07 | Transaction in Own Shares and Total Voting Rights |
| 9 Apr 2026 | Annual Report and Accounts (to 2025-12-31) |
Fortis Frontier PLC operates as a cash shell following the disposal of its trading subsidiary, Concepta Diagnostics Limited, which specialized in at-home healthcare and wellness tests. The company is now focused on evaluating strategic options to maximize shareholder value, including potential reverse takeover opportunities. Fortis Frontier is primarily engaged in managing its cash resources and assessing investment prospects in various sectors.
| 15 Sept 2026 | 07:00:03 | Half-Year Report |
| 14 May 2026 | 15:51:34 | Change of Registered Office |
| 11 May 2026 | 13:27:52 | Holding(s) in Company |
| 11 May 2026 | 13:11:51 | Holding(s) in Company |
| 11 May 2026 | 13:08:07 | Transaction in Own Shares and Total Voting Rights |
| 9 Apr 2026 | Annual Report and Accounts (to 2025-12-31) |
Fortis Frontier PLC operates as a cash shell following the disposal of its trading subsidiary, Concepta Diagnostics Limited, which specialized in at-home healthcare and wellness tests. The company is now focused on evaluating strategic options to maximize shareholder value, including potential reverse takeover opportunities. Fortis Frontier is primarily engaged in managing its cash resources and assessing investment prospects in various sectors.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £41.93bn | +0.0% | |
| £7.48bn | +0.2% | |
| £5.38bn | -0.2% | |
| £3m | +2.0% | |
| £441k | — | |
FORFFortis Frontier PLC | — | — |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £41.93bn | +0.0% | |
| £7.48bn | +0.2% | |
| £5.38bn | -0.2% | |
| £3m | +2.0% | |
| £441k | — | |
FORFFortis Frontier PLC | — | — |
